A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH CHEMO-REFRACTORY COLORECTAL CANCER

被引:0
|
作者
Oishi, Takayuki [1 ]
Takahashi, Masanobu [2 ]
Shiono, Masatoshi [2 ]
Takahashi, Shin [1 ]
Akiyama, Shoko [2 ]
Shirota, Hidekazu [2 ]
Shimodaira, Hideki [2 ]
Kato, Shunsuke [1 ]
Ishioka, Chikashi [1 ]
机构
[1] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan
关键词
D O I
10.1093/annonc/mdu436.27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-12-2
引用
收藏
页数:1
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTIVENESS OF PANITUMUMAB VERSUS CETUXIMAB IN PATIENTS WITH CHEMO-REFRACTORY WILD-TYPE KRAS METASTATIC COLORECTAL CANCER
    Xu, Y.
    Hay, J. W.
    Barzi, A.
    VALUE IN HEALTH, 2016, 19 (03) : A2 - A2
  • [32] COPERNIC: A study of on-treatment circulating tumour (ct) DNA changes in chemo-refractory colorectal cancer (CRC) patients
    Assaf, I.
    Bregni, G.
    Anthoine, G.
    Aparicio, T.
    Artru, P.
    Ben Abdelghani, M.
    Chibaudel, B.
    Coart, E.
    Diaz, M.
    Evrard, C.
    Geboes, K.
    Ghiringhelli, F.
    Puleo, F.
    Raimbourg, J.
    Vandamme, T.
    van den Eynde, M.
    Hendlisz, A.
    Sclafani, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S70 - S71
  • [33] Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
    Calcagno, Fabien
    Lenoble, Sabrina
    Lakkis, Zaher
    Nguyen, Thierry
    Limat, Samuel
    Borg, Christophe
    Jary, Marine
    Kim, Stefano
    Nerich, Virginie
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 59 - 66
  • [34] Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial
    Vandeputte, C.
    Bregni, G.
    Paraskevas, G.
    Guiot, T.
    Kehagias, P.
    Deleporte, A.
    Geboes, K.
    Delaunoit, T.
    Demolin, G.
    Peeters, M.
    D'Hondt, L.
    Janssens, J.
    Carrasco, J.
    Holbrechts, S.
    Goeminne, J.
    Vergauwe, P.
    Van Laethem, J.
    Flamen, P.
    Hendlisz, A.
    Sclafani, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S191 - S192
  • [35] Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
    Vandeputte, Caroline
    Bregni, Giacomo
    Gkolfakis, Paraskevas
    Guiot, Thomas
    Pretta, Andrea
    Kehagias, Pashalina
    Senti, Chiara
    Reina, Elena Acedo
    Van Bogaert, Camille
    Deleporte, Amelie
    Geboes, Karen
    Delaunoit, Thierry
    Demolin, Gauthier
    Peeters, Marc
    D'Hondt, Lionel
    Janssens, Jos
    Carrasco, Javier
    Holbrechts, Stephane
    Goeminne, Jean-Charles
    Vergauwe, Philippe
    Van Laethem, Jean-Luc
    Flamen, Patrick
    Hendlisz, Alain
    Sclafani, Francesco
    CLINICAL COLORECTAL CANCER, 2021, 20 (04) : 326 - 333
  • [36] Retrospective analysis of the efficacy and safety of nivolumab in patients with treatment-refractory esophageal cancer
    Kobayashi, Toshiaki
    Oda, Hiroyasu
    Sukeno, Koushi
    Tsunoda, Akira
    Tono, Yasutaka
    Ishihara, Mikiya
    Saito, Kanako
    Yamashita, Yoshiki
    Mizuno, Toshiro
    ANNALS OF ONCOLOGY, 2021, 32 : S328 - S328
  • [37] A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
    Powles, T.
    Savage, P. M.
    Stebbing, J.
    Short, D.
    Young, A.
    Bower, M.
    Pappin, C.
    Schmid, P.
    Seckl, M. J.
    BRITISH JOURNAL OF CANCER, 2007, 96 (05) : 732 - 737
  • [38] SAFETY AND EFFICACY OF REGORAFENIB IN JAPANESE PATIENTS WITH METASTATIC COLORECTAL CANCER: A SUBGROUP ANALYSIS OF THE PHASE III CORRECT TRIAL
    Yamada, Y.
    Yoshino, T.
    Komatsu, Y.
    Yamazaki, K.
    Tsuji, A.
    Ura, T.
    Grothey, A.
    Van Cutsem, E.
    Wagner, A.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2013, 24
  • [39] Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
    Xu, Donghao
    Liu, Yu
    Tang, Wentao
    Xu, Lingsha
    Liu, Tianyu
    Jiang, Yudong
    Zhou, Shizhao
    Qin, Xiaorui
    Li, Jisheng
    Zhao, Jiemin
    Ye, Lechi
    Chang, Wenju
    Xu, Jianmin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
    T Powles
    P M Savage
    J Stebbing
    D Short
    A Young
    M Bower
    C Pappin
    P Schmid
    M J Seckl
    British Journal of Cancer, 2007, 96 : 732 - 737